Examining the fastest growing sector in the biopharmaceutical market, this book discusses the advancement of protein drug development using peptides and proteins as the basis for prophylactic agents such as newly developed vaccines. As in the first two editions, this book employs a simple and straightforward style to discuss protein formulation and delivery from the basic to the more complex factors affecting protein stability and delivery. This third edition includes new information on insulin analogs, monoclonals, microneedles, and U.S. FDA guidelines.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.